| Literature DB >> 24240729 |
Vasco Sequeira1, E Rosalie Witjas-Paalberends, Diederik W D Kuster, Jolanda van der Velden.
Abstract
Cardiac myosin-binding protein C (cMyBP-C) research has been characterized by two waves. Initial interest was piqued by its discovery in 1973 as a contaminant of myosin preparations from skeletal muscle. The second wave started in 1995 by the discovery that mutations in the gene encoding cMyBP-C cause hypertrophic cardiomyopathy (HCM). In this review, we will address what is known of cMyBP-C's role as a regulator of contraction as well as its role in HCM.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24240729 DOI: 10.1007/s00424-013-1400-3
Source DB: PubMed Journal: Pflugers Arch ISSN: 0031-6768 Impact factor: 3.657